Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe Record History now includes a new version entry dated 2025-11-25 (version 169) with Study Status updates, and the 2025-11-17 entry was removed.SummaryDifference0.1%

- Check43 days agoChange DetectedThe revision history now lists an added Revision: v3.3.2 and removes the previous Revision: v3.2.0.SummaryDifference0.0%

- Check50 days agoChange DetectedVersion 168 posted 2025-11-17 adds updated Study Status and Contacts/Locations. The 2025-09-03 funding notice banner was removed.SummaryDifference0.3%

- Check64 days agoChange DetectedThe history shows routine new version entries, including the latest update posted 2025-09-03, with no substantive changes to the study’s status, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference6%

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.